Peptide

GDF-11

Also known as

GDF11 · growth differentiation factor 11

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Growth-factor protein	A TGF-beta-family signaling protein discussed for stamina, cognition and healthy aging. It is related to myostatin but is a different protein.
Young-blood theory	Mouse findings inspired replacement claims, but the idea that human GDF11 simply declines with age is disputed.

Notes

GDF-11 is a signaling protein that longevity experimenters inject in hopes of improving stamina, cognition and aging-related health. Accounts include feeling little change, claimed endurance gains and unpleasant reactions. The reported amounts are unusually small, and neither a typical human response nor a safe anti-aging dose is established.

A growth-factor protein. GDF11 belongs to the TGF-beta family, a group of proteins that help cells communicate about growth and development. It is closely related to myostatin, also called GDF8, but is a different protein. Similarity between them has complicated blood measurements. Schafer et al. — Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease (Official context · Accessed 2026-09-30)

The “young blood” idea. Longevity discussion grew from mouse experiments suggesting that adding GDF11 could restore youthful tissue function. Replacing an age-related deficiency sounds straightforward, but that premise is disputed: a human study distinguishing GDF11 from myostatin did not find GDF11 declining with age. Introduction to GDF-11 (Community guide · Accessed 2026-09-30) · Schafer et al. — Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease (Official context · Accessed 2026-09-30)

Source context — Schafer et al. — Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease: Observational endogenous measurements, not supplementation, half-life or causal treatment effects. PMC full text returned browser challenge.

Source context — Introduction to GDF-11: Commercial consulting references; intravenous-only assertion not adopted as required route; relative dates not converted.

What people notice

Stamina or little change	One user later described heavy yard work with little fatigue after initially feeling nothing. Other users reported no strength, endurance or promoted biomarker improvement.
Short-lived symptom relief	Accounts include only hours of relief and a secondhand apparent ME/CFS remission that weakened after 3–4 weeks. These do not establish recovery or a typical response.

Notes

Stamina and muscle are hoped-for benefits. Steven_Ow initially felt no difference after about two months with rapamycin, despite reported muscle gain. Later he described sustained heavy yard work with little fatigue. Exercise complicates attribution. GDF-11 supplementation in addition to Rapamycin (Community discussion · Accessed 2026-09-30)

A strength-focused user noticed nothing. Rocket reported no strength, endurance, weight or blood-panel improvement. Replies quoting his account are repetitions of one story. His experience disagrees with muscle-gain claims but does not prove nobody can notice a change. GDF11 interview discussion, Rocket’s nonresponse (Personal report · Accessed 2026-09-30)

Tracking can contradict a success story. Paul reported worse heart-rate variability and no promoted biomarker improvement. Testing reaction time daily improved his scores more than weekly testing. His later daily measurements and quarterly blood work reinforced nonresponse rather than providing independent corroborating users. GDF11 experience and tracking in Anyone trying something a little more edgy? (Community discussion · Accessed 2026-09-30)

Hours, days and no noticeable effect all appear. CaptainA described only a couple of hours of relief after injections, with diminishing effects; low energy and brain fog remained. On another page, beatsmyth described about three days of rebound energy without stating the amount. These are different users, not a measured duration range. GDF11 discussion, follow-up page4 (Community discussion · Accessed 2026-09-30) · GDF11 discussion, energy and maintenance lore page6 (Community discussion · Accessed 2026-09-30)

The remission headline did not stay the whole story. Hip later relayed that Hamsterman’s apparent remission lasted around three to four weeks and then weakened while the amount changed. Fever and malaise accompanied higher amounts in that account; they are not proof of clearing an infection. Hip’s own experience included irritability without initial symptom benefit. GDF11 discussion, follow-up page4 (Community discussion · Accessed 2026-09-30) · ME/CFS patient goes into remission after taking GDF11 (Community discussion · Accessed 2026-09-30)

Source context — GDF-11 supplementation in addition to Rapamycin: Unverified product and concurrent interventions; developer symptoms are secondhand; no preparation instructions reproduced.

Source context — GDF11 interview discussion, Rocket’s nonresponse: Self-report without verified material or controlled comparator; no adoption of recommendations for alternative compounds.

Source context — GDF11 experience and tracking in Anyone trying something a little more edgy?: One Paul history with follow-up; unknown route, product and initial frequency. “Biweekly” ambiguous. Tracking duration is not exposure duration.

Source context — GDF11 discussion, follow-up page4: Secondhand update and separate personal reports; route not established for CaptainA on this page; transient benefit is not cure.

Source context — GDF11 discussion, energy and maintenance lore page6: Amount and exact route unstated for energy account. Vortex repeats theory rather than a measured half-life or verified receptor finding.

Source context — ME/CFS patient goes into remission after taking GDF11: Edited 2020 thread: no controlled comparator or product verification; no proven infection clearance or pregnancy outcome.

Doses people talk about

Picograms: one SubQ account	200 pg every other day, later 400 pg every other day. These are per-injection amounts, not daily totals.
Separate picogram history	Another user reported up to 300 pg with initial route/frequency unstated, later 150 pg weekly and 75 pg “biweekly.” That last interval is ambiguous.
Nanograms: older account	8 ng/day, then 16 ng/day, later 8 ng every other day after reflux. Route was not stated; this is separate from the much smaller picogram reports.
Vial amount is not dose	10 mcg described a whole vial, not a 10–100 mcg injection band. One mcg equals 1,000 ng or 1,000,000 pg.

Notes

Picogram accounts: amounts per injection. Hip reports 200 pg subcutaneously every other day, later 400 pg every other day. Those are per-use amounts, not daily totals. Paul reports up to 300 pg with initial frequency and route unstated, then 150 pg weekly and 75 pg “biweekly”; that last interval is ambiguous. ME/CFS patient goes into remission after taking GDF11 (Community discussion · Accessed 2026-09-30) · GDF11 experience and tracking in Anyone trying something a little more edgy? (Community discussion · Accessed 2026-09-30)

Nanogram accounts are a separate history. In 2017, SONOFDARTH described 8 ng/day, then 16 ng/day, later 8 ng every other day after reflux. The route is not specified in that update. These amounts must not be combined with the much smaller picogram reports into one usual range. GDF11 vs BPC157: experiences & technique (Personal report · Accessed 2026-09-30)

Vial contents are not the dose. The forum’s 10 mcg figure describes total vial contents. One mcg equals 1,000 ng or 1,000,000 pg. It does not support a 10–100 mcg injection range or verify product contents. GDF-11 supplementation in addition to Rapamycin (Community discussion · Accessed 2026-09-30)

Source context — ME/CFS patient goes into remission after taking GDF11: Edited 2020 thread: no controlled comparator or product verification; no proven infection clearance or pregnancy outcome.

Source context — GDF11 vs BPC157: experiences & technique: Older nanogram account; amount/form unverified, route unstated in dose update; other compounds complicate attribution.

Source context — GDF-11 supplementation in addition to Rapamycin: Unverified product and concurrent interventions; developer symptoms are secondhand; no preparation instructions reproduced.

Half-life, onset & duration

Felt onset	No repeatable first-dose onset. A secondhand account described change in month two with NMN also used; another user's initial 25-day experiment brought no ME/CFS improvement.
Felt duration	One user described only a couple of hours of relief; a different user described about three days of rebound energy without an amount. These do not establish a usual window.
Half-life	No dependable human number is established here. Injection intervals, energy reports and receptor theories do not measure blood clearance.

Notes

No typical first-dose onset. No repeatable minutes-to-hours benefit emerges. LukeMV noticed no subjective effect; other reports describe repeated use. GDF11 experience and tracking in Anyone trying something a little more edgy? (Community discussion · Accessed 2026-09-30)

A second-month story is one person’s timeline. Hip relayed Hamsterman’s claimed ME/CFS remission after two months, with little change in the first month beyond sleep and morning improvement. NMN was also being used. Hip’s own 25-day experiment had produced no ME/CFS improvement at his initial report. ME/CFS patient goes into remission after taking GDF11 (Community discussion · Accessed 2026-09-30)

No dependable community half-life number. These accounts describe how often people inject, not how quickly GDF11 leaves the body. Weekly maintenance, a three-day energy report and claims about receptor changes do not measure half-life or provide a clearance interval. GDF11 discussion, energy and maintenance lore page6 (Community discussion · Accessed 2026-09-30)

Source context — ME/CFS patient goes into remission after taking GDF11: Edited 2020 thread: no controlled comparator or product verification; no proven infection clearance or pregnancy outcome.

Source context — GDF11 discussion, follow-up page4: Secondhand update and separate personal reports; route not established for CaptainA on this page; transient benefit is not cure.

Cycles people discuss

Long use, changing intervals	One user reported three years of injection use and once-weekly timing. Another reduced amounts over months; a five-year tracking history does not prove continuous exposure.
Maintenance theory	Claims of daily use hitting a wall after 2–3 months and needing smaller maintenance amounts are community theory, not a verified tolerance or restart rule.

Notes

Long use with changing intervals. DrT reported three years of injection use and specified once weekly. Paul reduced amounts over months; his five-year spreadsheet history does not establish continuous exposure. No shared seasonal course emerges. GDF-11 supplementation in addition to Rapamycin (Community discussion · Accessed 2026-09-30) · GDF11 experience and tracking in Anyone trying something a little more edgy? (Community discussion · Accessed 2026-09-30)

“Downregulation” is community theory. Vortex repeats a claim that daily use hits a wall after two to three months and then needs very small maintenance amounts. That account explains circulated protocol lore, not a verified mechanism, tolerance timetable or restart rule. GDF11 discussion, energy and maintenance lore page6 (Community discussion · Accessed 2026-09-30)

Source context — GDF-11 supplementation in addition to Rapamycin: Unverified product and concurrent interventions; developer symptoms are secondhand; no preparation instructions reproduced.

Stacks

Rapamycin and Klotho	These appear in longevity accounts alongside exercise. Good fitness and improved test scores do not identify GDF11's contribution.
Metformin or NMN	One tracking history also included rapamycin, metformin and keto eating; the secondhand remission story included NMN. They are different accounts, not one proven stack.

Notes

Good fitness did not settle whether it helped. DrT had energy, clean artery scans and lower reaction times, yet lacked concrete evidence of benefit. Genetics, exercise, rapamycin, Klotho, repeated practice and an unreliable blood-pressure meter complicated attribution. GDF-11 supplementation in addition to Rapamycin (Community discussion · Accessed 2026-09-30)

One uncertain AFIB report. Paul described a first episode of atrial fibrillation, an abnormal heart rhythm, about two weeks after changing to 75 pg “biweekly.” He explicitly left the connection uncertain. His history also included rapamycin, metformin, keto eating and regular exercise. GDF11 experience and tracking in Anyone trying something a little more edgy? (Community discussion · Accessed 2026-09-30)

Source context — GDF-11 supplementation in addition to Rapamycin: Unverified product and concurrent interventions; developer symptoms are secondhand; no preparation instructions reproduced.

Source context — ME/CFS patient goes into remission after taking GDF11: Edited 2020 thread: no controlled comparator or product verification; no proven infection clearance or pregnancy outcome.

Watch for

Agitation and reflux	One user described agitation/aggression lasting around four days after injections. A separate older account developed persistent reflux after roughly 12 days.
Uncertain heart-rhythm report	One user reported a first AFIB episode after an interval change and explicitly left the connection uncertain; other drugs and lifestyle changes were also involved.
Animal harm is separate	High recombinant-GDF11 exposure caused severe muscle/organ weight loss and death in mice. It does not establish a safe human amount.
Product and long-term risks	Impurities, allergy, injection reactions, interactions and long-term safety remain unresolved. Pregnancy concerns also appear because GDF11 participates in embryo development.

Notes

Unpleasant effects can outlast the hoped-for relief. Hip’s follow-up describes agitation and aggression lasting around four days after injections. That is one adverse-effect account, not four days of rejuvenation or a bodily half-life. GDF11 discussion, follow-up page4 (Community discussion · Accessed 2026-09-30)

Reflux and other early symptoms. SONOFDARTH reported persistent reflux after roughly 12 days. Another discussion repeats a developer’s severe early symptoms secondhand. Adverse symptoms are not evidence that rejuvenation is starting. GDF11 vs BPC157: experiences & technique (Personal report · Accessed 2026-09-30)

Animal findings give a separate warning. In Harper’s mouse study, high recombinant-GDF11 exposure caused severe loss of muscle and organ weight and death. The highest amount was 5 mg/kg/day. That animal result cannot supply a safe human amount or be converted into a community injection dose. Harper et al. — GDF11 and pressure-overload hearts (Animal context · Accessed 2026-09-30)

Product quality and long-term use remain uncertain. Unknown impurities and allergic or injection-site reactions are concerns for unverified preparations; redness, itching, lumps and bruising do not establish product identity. Interactions and long-term safety are unresolved. Severe allergy, chest pain, sudden neurological changes, or uncontrolled blood pressure or blood sugar need medical attention.

Pregnancy questions are unresolved. Hip raised pregnancy concerns because GDF11 is involved in embryo development, while acknowledging uncertainty about whether supplemental protein crosses the placenta. That is a community caution, not a demonstrated pregnancy outcome or a safety assurance. ME/CFS patient goes into remission after taking GDF11 (Community discussion · Accessed 2026-09-30)

Source context — GDF11 discussion, follow-up page4: Secondhand update and separate personal reports; route not established for CaptainA on this page; transient benefit is not cure.

Source context — GDF11 vs BPC157: experiences & technique: Older nanogram account; amount/form unverified, route unstated in dose update; other compounds complicate attribution.

Source context — Harper et al. — GDF11 and pressure-overload hearts: Primary abstract mirror only; PMC full text challenged, publisher open failed. Not human dosage, safety or pharmacokinetics.

Source context — ME/CFS patient goes into remission after taking GDF11: Edited 2020 thread: no controlled comparator or product verification; no proven infection clearance or pregnancy outcome.

Full notes

What GDF-11 actually is

A growth-factor protein. GDF11 belongs to the TGF-beta family, a group of proteins that help cells communicate about growth and development. It is closely related to myostatin, also called GDF8, but is a different protein. Similarity between them has complicated blood measurements. Official context
The “young blood” idea. Longevity discussion grew from mouse experiments suggesting that adding GDF11 could restore youthful tissue function. Replacing an age-related deficiency sounds straightforward, but that premise is disputed: a human study distinguishing GDF11 from myostatin did not find GDF11 declining with age. Community guide Official context
Injection accounts need their actual route. DrT describes subcutaneous use: under the skin. Other accounts leave the route unstated. An older forum’s intravenous-only assertion does not describe all reported use. Lab-made GDF11 protein differs from short organ-targeted bioregulator capsules. Rapamycin News Community guide

Why people try it

Stamina and muscle are hoped-for benefits. Steven_Ow initially felt no difference after about two months with rapamycin, despite reported muscle gain. Later he described sustained heavy yard work with little fatigue. Exercise complicates attribution. Rapamycin News
Better cognition and heart measurements are promoted. A commercial GDF11 advisory service advertises improved reaction time, heart-rate variability and stamina. Heart-rate variability describes changes in the time between heartbeats. Its uncontrolled client claims do not establish age reversal or a dependable benefit. Community guide

Doses people discuss

Picogram accounts: amounts per injection. Hip reports 200 pg subcutaneously every other day, later 400 pg every other day. Those are per-use amounts, not daily totals. Paul reports up to 300 pg with initial frequency and route unstated, then 150 pg weekly and 75 pg “biweekly”; that last interval is ambiguous. Phoenix Rising Rapamycin News
Nanogram accounts are a separate history. In 2017, SONOFDARTH described 8 ng/day, then 16 ng/day, later 8 ng every other day after reflux. The route is not specified in that update. These amounts must not be combined with the much smaller picogram reports into one usual range. Personal report
Vial contents are not the dose. The forum’s 10 mcg figure describes total vial contents. One mcg equals 1,000 ng or 1,000,000 pg. It does not support a 10–100 mcg injection range or verify product contents. Rapamycin News

Half-life discussed in the community

No dependable community half-life number. These accounts describe how often people inject, not how quickly GDF11 leaves the body. Weekly maintenance, a three-day energy report and claims about receptor changes do not measure half-life or provide a clearance interval. Phoenix Rising

When people notice a change

No typical first-dose onset. No repeatable minutes-to-hours benefit emerges. LukeMV noticed no subjective effect; other reports describe repeated use. Rapamycin News
A second-month story is one person’s timeline. Hip relayed Hamsterman’s claimed ME/CFS remission after two months, with little change in the first month beyond sleep and morning improvement. NMN was also being used. Hip’s own 25-day experiment had produced no ME/CFS improvement at his initial report. Phoenix Rising

How long reported effects last

Hours, days and no noticeable effect all appear. CaptainA described only a couple of hours of relief after injections, with diminishing effects; low energy and brain fog remained. On another page, beatsmyth described about three days of rebound energy without stating the amount. These are different users, not a measured duration range. Phoenix Rising Phoenix Rising
Unpleasant effects can outlast the hoped-for relief. Hip’s follow-up describes agitation and aggression lasting around four days after injections. That is one adverse-effect account, not four days of rejuvenation or a bodily half-life. Phoenix Rising

Courses and breaks people describe

Long use with changing intervals. DrT reported three years of injection use and specified once weekly. Paul reduced amounts over months; his five-year spreadsheet history does not establish continuous exposure. No shared seasonal course emerges. Rapamycin News Rapamycin News
“Downregulation” is community theory. Vortex repeats a claim that daily use hits a wall after two to three months and then needs very small maintenance amounts. That account explains circulated protocol lore, not a verified mechanism, tolerance timetable or restart rule. Phoenix Rising

Good to know

Reflux and other early symptoms. SONOFDARTH reported persistent reflux after roughly 12 days. Another discussion repeats a developer’s severe early symptoms secondhand. Adverse symptoms are not evidence that rejuvenation is starting. Personal report Community
One uncertain AFIB report. Paul described a first episode of atrial fibrillation, an abnormal heart rhythm, about two weeks after changing to 75 pg “biweekly.” He explicitly left the connection uncertain. His history also included rapamycin, metformin, keto eating and regular exercise. Rapamycin News
Animal findings give a separate warning. In Harper’s mouse study, high recombinant-GDF11 exposure caused severe loss of muscle and organ weight and death. The highest amount was 5 mg/kg/day. That animal result cannot supply a safe human amount or be converted into a community injection dose. Animal context
Product quality and long-term use remain uncertain. Unknown impurities and allergic or injection-site reactions are concerns for unverified preparations; redness, itching, lumps and bruising do not establish product identity. Interactions and long-term safety are unresolved. Severe allergy, chest pain, sudden neurological changes, or uncontrolled blood pressure or blood sugar need medical attention. Community
Storage claims depend on the product. General discussion describes unopened products kept cool, dry and out of light according to seller labels. Storage after opening is product-specific; there is no universal forum shelf-life that verifies sterility or continued activity. Community
Pregnancy questions are unresolved. Hip raised pregnancy concerns because GDF11 is involved in embryo development, while acknowledging uncertainty about whether supplemental protein crosses the placenta. That is a community caution, not a demonstrated pregnancy outcome or a safety assurance. Phoenix Rising

What the experiences add

Good fitness did not settle whether it helped. DrT had energy, clean artery scans and lower reaction times, yet lacked concrete evidence of benefit. Genetics, exercise, rapamycin, Klotho, repeated practice and an unreliable blood-pressure meter complicated attribution. Rapamycin News
A strength-focused user noticed nothing. Rocket reported no strength, endurance, weight or blood-panel improvement. Replies quoting his account are repetitions of one story. His experience disagrees with muscle-gain claims but does not prove nobody can notice a change. Personal report
Tracking can contradict a success story. Paul reported worse heart-rate variability and no promoted biomarker improvement. Testing reaction time daily improved his scores more than weekly testing. His later daily measurements and quarterly blood work reinforced nonresponse rather than providing independent corroborating users. Rapamycin News
The remission headline did not stay the whole story. Hip later relayed that Hamsterman’s apparent remission lasted around three to four weeks and then weakened while the amount changed. Fever and malaise accompanied higher amounts in that account; they are not proof of clearing an infection. Hip’s own experience included irritability without initial symptom benefit. Phoenix Rising Phoenix Rising
Benefit in one organ would not settle the whole-body question. Reddit discussion debates whether possible brain or heart effects could outweigh adverse liver findings. Those are opinions about research, not firsthand outcomes; the debate itself does not resolve human effectiveness or safety. Reddit